
Uncover the next big thing with 22 elite penny stocks that balance risk and reward.
To own BXP today, you need to believe high quality office and life science space in gateway markets can keep attracting tenants despite industry headwinds. The recent FFO outlook raise supports that thesis by pointing to better near term fundamentals, but it does not remove key risks around leasing up new developments, backfilling move outs, and keeping occupancy from slipping as projects come online.
The most relevant recent announcement here is BXP’s US$1.2 billion construction loan for 343 Madison Avenue, a US$2 billion flagship development in Midtown Manhattan. The project could be a powerful earnings driver if leasing and cash yields progress as planned, but it also concentrates capital allocation and leverage risk at a time when higher interest costs and slower leasing in some segments are already in focus.
Yet beneath this improving FFO outlook, one risk investors should be aware of is how large, capital intensive projects like 343 Madison could...
Read the full narrative on BXP (it's free!)
BXP's narrative projects $3.7 billion revenue and $343.6 million earnings by 2029. This requires 4.9% yearly revenue growth and about a $46.8 million earnings increase from $296.8 million today.
Uncover how BXP's forecasts yield a $75.15 fair value, a 7% upside to its current price.
Some of the lowest estimate analysts paint a much more pessimistic picture, with earnings drifting toward about US$290.1 million on roughly US$3.8 billion of revenue, so if you lean closer to that view, this upbeat FFO update and your concerns about higher construction and financing costs might both influence how you interpret BXP’s next few years.
Explore 3 other fair value estimates on BXP - why the stock might be worth as much as 27% more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Every day counts. These free picks are already gaining attention. See them before the crowd does:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com